Skip to main content
. Author manuscript; available in PMC: 2023 Sep 15.
Published in final edited form as: Toxicol Appl Pharmacol. 2022 Jul 8;451:116161. doi: 10.1016/j.taap.2022.116161

Fig. 4. Genes in dysregulated pathways enriched in tissue-specific manner in either liver or muscle:

Fig. 4.

Heatmap showing genes involved in response to oxidative stress in the liver (left) and RNA biosynthetic process in the muscle (right) that are dysregulated by prenatal BPA-treatment at FDR < 0.01. The normalized counts of genes in the respective pathways in each tissue from control and prenatal BPA-treated animals are represented as a gradient of colors with blue representing the highest and yellow representing the lowest.